DAVID W GRYSKA Insider Trading $PDLI PDL BIOPHARMA, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID W GRYSKA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID W GRYSKA. DAVID W GRYSKA is Executive Vice President, CFO in INCYTE CORP ($INCY) and Director in PDL BIOPHARMA, INC. ($PDLI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in COTHERIX INC ($CTRX) and Director in AERIE PHARMACEUTICALS INC ($AERI) and Director in GW PHARMACEUTICALS PLC ($GWPH).
DAVID W GRYSKA in PDL BIOPHARMA, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID W GRYSKA: Director
Holdings: 1,387 shares
Current Value: $3,065
Latest Transaction: Dec 31 2020
$PDLI Market Capitalization: $367.50M
$PDLI Previous Close: $2.21
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID W GRYSKA in PDL BIOPHARMA, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AERI, CTRX, GWPH, INCY, PDLI, SGEN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Sell | S | 2.74 | 20,000 | 54,800 | 1,387 | 21.4 K to 1.4 K (-93.51 %) |
| Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Sell | S | 2.68 | 75,000 | 201,000 | 21,387 | 96.4 K to 21.4 K (-77.81 %) |
| Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Sell | S | 2.68 | 75,000 | 201,000 | 21,387 | 96.4 K to 21.4 K (-77.81 %) |
| Dec 04 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Sell | S | 2.52 | 75,000 | 189,000 | 30,337 | 105.3 K to 30.3 K (-71.20 %) |
| Dec 04 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Sell | S | 2.52 | 75,000 | 189,000 | 30,337 | 105.3 K to 30.3 K (-71.20 %) |
| Nov 19 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Sell | S | 2.39 | 50,000 | 119,500 | 95,337 | 145.3 K to 95.3 K (-34.40 %) |
| Nov 19 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Sell | S | 2.40 | 100,000 | 240,000 | 145,337 | 245.3 K to 145.3 K (-40.76 %) |
| Aug 24 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Option Exercise | A | 3.63 | 118,671 | 430,776 | 118,671 | |
| Aug 24 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Grant | A | 0.00 | 25,826 | 0 | 245,337 | 219.5 K to 245.3 K (+11.77 %) |
| Jun 24 2019 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Option Exercise | A | 3.00 | 126,050 | 378,150 | 126,050 | |
| Jun 24 2019 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Option Exercise | A | 3.00 | 126,050 | 378,150 | 126,050 | |
| Jun 12 2017 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Grant | A | 2.47 | 60,729 | 150,001 | 165,163 | 104.4 K to 165.2 K (+58.15 %) |
| Jun 03 2016 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Grant | A | 3.52 | 71,023 | 250,001 | 104,434 | 33.4 K to 104.4 K (+212.57 %) |
| May 29 2015 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Grant | A | 6.80 | 22,059 | 150,001 | 33,411 | 11.4 K to 33.4 K (+194.32 %) |
Page: 1